Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000899140-25-000572
Filing Date
2025-05-02
Accepted
2025-05-02 17:14:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11010
2 EXHIBIT A s122779777a.htm EX-99.1 7409
3 EXHIBIT B s122779777b.htm EX-99.2 839
  Complete submission text file 0000899140-25-000572.txt   20947
Mailing Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022
Business Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022 2127025204
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001569064 (see all company filings)

EIN.: 453704500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address WAGISTRASSE 14 Z?RICH-SCHLIEREN V8 8952
Business Address WAGISTRASSE 14 Z?RICH-SCHLIEREN V8 8952 41 44 755 77 00
MOLECULAR PARTNERS AG (Subject) CIK: 0001745114 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92857 | Film No.: 25909920
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)